SIGA Technologies Inc. (SIGA) financial statements (2021 and earlier)

Company profile

Business Address 31 EAST 62ND STREET
NEW YORK, NY 10065
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments118651012029113100
Cash and cash equivalents118651012029113100
Restricted cash and investments 96111110  
Receivables3422340
Inventory, net of allowances, customer advances and progress billings201033261219
Inventory201033261219
Other undisclosed current assets25421111
Total current assets:1441801213769129130
Noncurrent Assets
Property, plant and equipment2300001
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Restricted cash and investments3 68717 4
Deferred costs   97735333
Other noncurrent assets1111122
Deferred tax assets, net122   
Other undisclosed noncurrent assets 14    (4)
Total noncurrent assets:61982107925637
TOTAL ASSETS:150199203145161186166
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1012117776
Accounts payable1321343
Accrued liabilities99105532
Employee-related liabilities      0
Debt 80    2
Other undisclosed current liabilities    7 (0)
Total current liabilities:10921171477
Noncurrent Liabilities
Liabilities, other than long-term debt   3783682566
Deferred revenue and credits3783672550
Deferred tax liabilities, net  006
Other undisclosed noncurrent liabilities109898367207399
Total noncurrent liabilities:10989461435463405
Total liabilities:20101101468448470413
Stockholders' equity
Stockholders' equity attributable to parent13098103(323)(287)(284)(247)
Common stock0000000
Additional paid in capital225221219214214177175
Accumulated deficit(95)(123)(116)(537)(501)(461)(422)
Total stockholders' equity:13098103(323)(287)(284)(247)
TOTAL LIABILITIES AND EQUITY:150199203145161186166

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues12527477    
Cost of revenue(16)(2)(95)(1)   
Cost of goods and services sold(15)  (1)   
Gross profit:10925382(1)   
Operating expenses(25)(29)(122)(31)(46)(39)(213)
Other undisclosed operating income 295131583
Operating income (loss):85(2)355(19)(31)(31)(210)
Nonoperating income13790000
Interest and debt expense(8)(16)(15)(15)(2)(0)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(4)5(7)(5)(6)(8)(2)
Income (loss) from continuing operations before income taxes:74(10)412(38)(40)(39)(212)
Income tax expense (benefit)(17)3102(0)(0)(54)
Net income (loss) available to common stockholders, diluted:56(7)422(36)(40)(39)(265)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):56(7)422(36)(40)(39)(265)
Comprehensive income (loss), net of tax, attributable to parent:56(7)422(36)(40)(39)(265)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: